- World rank, all time
- #29,764 of 42,892
- Rank in Japan
- #1,216 of 2,112
- Research works
- 212 ◆ 0% vs 2013–17
- Citations
- 3.1k 14.6 per fractional work
- Top-10% rate
- 10.7% record average 16.5%
- Open access
- 53% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 7.8×
- Veterinary 2.7×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Medicine 2.3×
- Chemistry 2.3×
- Immunology and Microbiology 1.7×
- Agricultural and Biological Sciences 1.5×
- Nursing 1.0×
- Neuroscience 0.9×
- Earth and Planetary Sciences 0.8×
- Engineering 0.8×
- Chemical Engineering 0.7×
- Physics and Astronomy 0.7×
- Materials Science 0.6×
- Environmental Science 0.6×
- Psychology 0.4×
- Economics, Econometrics and Finance 0.3×
- Computer Science 0.2×
- Social Sciences 0.2×
- Mathematics 0.1×
- Health Professions 0.1×
Which keywords describe research at ASKA Pharmaceutical (Japan)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Oxidative Stress, Immune Response, Antioxidants, Vaccine, SARS-CoV-2, Metabolic Syndrome and Inflammation.
- Vaccine
- Antioxidants
- Immune Response
- Oxidative Stress
- Epidemiology
- Inflammation
- Metabolic Syndrome
- SARS-CoV-2
- Pandemic
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 9 words, with their numbers
- Epidemiology3▲ 2.0×16 topics
- Oxidative Stress2▲ 3.5×12 topics
- Inflammation1▲ 1.94×9 topics
- Immune Response1▲ 6.6×6 topics
- Metabolic Syndrome1▲ 4.5×7 topics
- Antioxidants1▲ 7.6×4 topics
- SARS-CoV-21▲ 9.9×3 topics
- Vaccine1▲ 8.0×3 topics
- Pandemic1▲ 2.9×3 topics
Which research topics does ASKA Pharmaceutical (Japan) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Psoriasis: Treatment and Pathogenesis, Multiple Myeloma Research and Treatments and Protein Degradation and Inhibitors.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 1 works
- 2 Psoriasis: Treatment and Pathogenesis Immunology 0 works
- 3 Multiple Myeloma Research and Treatments Hematology 0 works
- 4 Protein Degradation and Inhibitors Molecular Biology 0 works
- 5 CAR-T cell therapy research Oncology 0 works
- 6 Skin Protection and Aging Dermatology 0 works
- 7 Phytochemicals and Antioxidant Activities Biochemistry 0 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 9 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 10 Effects of Environmental Stressors on Livestock Animal Science and Zoology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ASKA Pharmaceutical (Japan)'s research output changed?
Output in 2018–2022 was 0% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tokyo
- The University of Tokyo
- Tokyo Institute of Technology
- Keio University
- Waseda University
- Tokyo University of Science
- Nihon University
- Hitachi (Japan)
- NTT (Japan)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.